Keywords: pharmacopeia, gets, 1m, s-p, drug, enters, ph
Pharmacopeia gets $1M as S-P drug enters Ph I
Article | 09 April 2007
Pharmacopeia has received a $1.0 million milestone payment, triggered by Schering-Plough's initiation of Phase I clinical trials of an inflammatory disease ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
